Holen Sie sich die Stockscreener-App
264.94
0.94%
2.71
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$262.23
Offen:
$262.22
24-Stunden-Volumen:
614.91K
Relative Volume:
0.33
Marktkapitalisierung:
$70.72B
Einnahmen:
$261.22B
Nettoeinkommen (Verlust:
$5.02B
KGV:
14.46
EPS:
18.32
Netto-Cashflow:
$3.94B
1W Leistung:
-9.47%
1M Leistung:
-17.22%
6M Leistung:
-9.18%
1J Leistung:
-21.53%
1-Tages-Spanne:
$260.12
$265.97
1-Wochen-Bereich:
$256.89
$298.71
52-Wochen-Spanne:
$256.89
$370.82
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Vergleichen Sie CI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
264.71 | 70.00B | 261.22B | 5.02B | 3.94B | 18.32 |
|
UNH
Unitedhealth Group Inc
|
239.33 | 215.69B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
62.14 | 79.23B | 386.64B | 4.53B | 4.78B | 3.58 |
|
ELV
Elevance Health Inc
|
278.91 | 61.85B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
247.28 | 29.74B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Elite Investors see life in Cigna - Citywire
Is The Cigna Group a good long term investmentMaximize portfolio growth with strategic plans - jammulinksnews.com
Cigna Group's Q2 2025 Earnings: Balancing Long-Term Growth in Evernorth with Near-Term Profitability Pressures - AInvest
Cigna Group Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
What are analysts’ price targets for The Cigna Group in the next 12 monthsAccess powerful market insights for free - jammulinksnews.com
Cigna Group abandons seeking merger with Humana - 富途牛牛
The Cigna Group Beat Revenue Forecasts By 7.2%: Here's What Analysts Are Forecasting Next - Yahoo Finance
A Quick Look at Today's Ratings for Cigna Group(CI.US), With a Forecast Between $336 to $390 - 富途牛牛
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened - Stocktwits
Cigna (CI) Q2 Revenue Jumps 11% - The Motley Fool
Cigna's Q2 2025 Earnings: Can Strategic Growth Offset Profit Stagnation for Long-Term Investors? - AInvest
The Cigna (CI) Group Falls 10% as Earnings Disappoint - MSN
Cigna price target lowered to $375 from $405 at Truist - MSN
How strong is The Cigna Group company’s balance sheetTop Growth Entry Points For Every Investor - jammulinksnews.com
Cigna Plunges 3.33% Amid Earnings Volatility and Sector Turmoil – What’s Next for CI? - AInvest
Why Cigna (CI) is a Great Dividend Stock Right Now - Yahoo Finance
Cigna Group's Strategic Resilience: Navigating Stop-Loss Challenges in a High-Cost Healthcare Era - AInvest
Cigna Group's Balanced Play Keeps Analysts On Board - Finimize
Cigna stock hits 52-week low at 261.66 USD - Investing.com Australia
Cigna stock hits 52-week low at 261.66 USD By Investing.com - Investing.com India
Cigna beats investor expectations on Evernorth growth - Healthcare Dive
The Cigna Group (NYSE:CI) Q2 2025 Earnings Call Transcript - Insider Monkey
Cigna Group posts US$1.5 billion in net income - Insurance Business America
Cigna Group reports US$1.5 billion in net income - Insurance Business America
Cigna Group posts $1.5 billion in net income - Insurance Business America
The Cigna Group (CI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Cost Pressures - Yahoo Finance
The Cigna Group (CI) Q2 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna Group Reports Strong Q2 2025 Earnings - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Massive Sell-Off: 10 Stocks in a Bloodbath - Insider Monkey
Cigna's $1.5B Surge to 82nd in Volume Amid 10.23% Drop as Earnings Clash with Market Trends - AInvest
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened By Stocktwits - Investing.com India
Cigna’s Earnings Call: Strong Results Amid Challenges - TipRanks
Cigna Group stock underperforms Thursday when compared to competitors - MSN
Cigna's solid Q2 results boosted by Evernorth revenue growth, limited exposure to elevated medical costs - Fierce Healthcare
What are The Cigna Group company’s key revenue driversAI Powered Tips For 2025 - jammulinksnews.com
Cigna's Positive Second Quarter Numbers Reflect Shift to Pharmaceutical Services - Managed Healthcare Executive
Cigna Group (CI) Reports Q2 Revenue Surge To US$67,178 Million, Net Income Flat - simplywall.st
Cigna Group SEC 10-Q Report - TradingView
Cigna battles hospitals' AI billing systems in escalating health care cost fight - BenefitsPRO
Cigna reaffirms guidance despite elevated medical costs - Healthcare Finance News
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes - Yahoo Finance
Earnings call transcript: Cigna Q2 2025 beats earnings estimates, stock dips By Investing.com - Investing.com Canada
Cigna Sees Elevated Cost Trends To Continue Into Next Year - Benzinga
Cigna: Q2 Earnings Snapshot - Chron
Earnings call transcript: Cigna Q2 2025 beats earnings estimates, stock dips - Investing.com
Cigna Stock Falls on Earnings Even as It Sidesteps the Managed-Care Crisis - Barron's
Cigna's health services business powers Q2 earnings beat - Reuters
Cigna affirms outlooks as Evernorth Health Services drives growth - Modern Healthcare
Cigna beats profit estimate on robust health services growth - Reuters
Cigna’s 2nd quarter profits beat Wall Street’s expectations - Fast Company
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):